401k Plan data: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN plan

TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 401k Plan overview

Plan Name	TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN
Plan identification number	001

TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN Benefits

401k Plan Type

Defined Benefit Pension

Plan Features/Benefits

Benefits are primarily pay related
Frozen Plan - As of the last day of the plan year, the plan provides that no participant will get any new benefit accrual (whether because of service or compensation).
Profit-sharing
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Participant-directed brokerage accounts provided as an investment option under the plan.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).
U.S.-based plan that covers residents of Puerto Rico and is qualified under both Code section 401 and section 1165 of the Puerto Rico Code.

401k Sponsoring company profile

TAKEDA PHARMACEUTICAL U.S.A., INC. has sponsored the creation of one or more 401k plans.

Company Name: TAKEDA PHARMACEUTICAL U.S.A., INC.

Employer identification number (EIN): 134013710

NAIC Classification: 339900

Form 5500 Filing Information

Submission information for form 5500 for 401k plan TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01 MATTHEW REGAN 2023-10-09
001 2021-01-01 MATTHEW REGAN 2022-10-08
001 2020-01-01 MATTHEW REGAN 2021-10-15 MATTHEW REGAN 2021-10-15
001 2019-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 NANCY SHOSTACK NANCY SHOSTACK 2018-10-10
001 2016-01-01 LAURENE GIAGNORIO HELEN GIZA 2017-10-12
001 2015-01-01 LAURENE GIAGNORIO HELEN GIZA 2016-10-13
001 2014-01-01 LAURENE GIAGNORIO HELEN GIZA 2015-10-13
001 2013-01-01 LAURENE GIAGNORIO HELEN PRING 2014-10-14
001 2012-01-01 HELEN PRING LAURENE GIAGNORIO 2013-10-07
001 2011-01-01 LAURENE GIAGNORIO HELEN PRING 2012-10-15
001 2009-01-01 LAURENE BENTEL HELEN PRING 2010-10-01

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01	MATTHEW REGAN	2023-10-09
001	2021-01-01	MATTHEW REGAN	2022-10-08
001	2020-01-01	MATTHEW REGAN	2021-10-15	MATTHEW REGAN	2021-10-15
001	2019-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	NANCY SHOSTACK		NANCY SHOSTACK	2018-10-10
001	2016-01-01	LAURENE GIAGNORIO		HELEN GIZA	2017-10-12
001	2015-01-01	LAURENE GIAGNORIO		HELEN GIZA	2016-10-13
001	2014-01-01	LAURENE GIAGNORIO		HELEN GIZA	2015-10-13
001	2013-01-01	LAURENE GIAGNORIO		HELEN PRING	2014-10-14
001	2012-01-01	HELEN PRING		LAURENE GIAGNORIO	2013-10-07
001	2011-01-01	LAURENE GIAGNORIO		HELEN PRING	2012-10-15
001	2009-01-01	LAURENE BENTEL		HELEN PRING	2010-10-01

Plan Statistics for TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN

401k plan membership statisitcs for TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN

Measure Date Value
2022: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 32,659
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 21,791
Number of retired or separated participants receiving benefits 2022-01-01 76
Number of other retired or separated participants entitled to future benefits 2022-01-01 13,625
Total of all active and inactive participants 2022-01-01 35,492
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 38
Total participants 2022-01-01 35,530
Number of participants with account balances 2022-01-01 34,335
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 3,021
2021: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 29,720
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 20,597
Number of retired or separated participants receiving benefits 2021-01-01 67
Number of other retired or separated participants entitled to future benefits 2021-01-01 12,707
Total of all active and inactive participants 2021-01-01 33,371
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 28
Total participants 2021-01-01 33,399
Number of participants with account balances 2021-01-01 32,369
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 2,860
2020: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 28,564
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 19,614
Number of retired or separated participants receiving benefits 2020-01-01 25
Number of other retired or separated participants entitled to future benefits 2020-01-01 10,971
Total of all active and inactive participants 2020-01-01 30,610
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 17
Total participants 2020-01-01 30,627
Number of participants with account balances 2020-01-01 29,473
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 303
2019: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2019 401k membership
Market value of plan assets 2019-12-31 240,170,494
Acturial value of plan assets 2019-12-31 258,027,347
Funding target for retired participants and beneficiaries receiving payment 2019-12-31 99,661,883
Number of terminated vested participants 2019-12-31 517
Fundng target for terminated vested participants 2019-12-31 70,533,320
Active participant vested funding target 2019-12-31 122,677,245
Number of active participants 2019-12-31 792
Total funding liabilities for active participants 2019-12-31 134,840,928
Total participant count 2019-12-31 1,536
Total funding target for all participants 2019-12-31 305,036,131
Balance at beginning of prior year after applicable adjustments 2019-12-31 0
Prefunding balance at beginning of prior year after applicable adjustments 2019-12-31 0
Carryover balanced portion elected for use to offset prior years funding requirement 2019-12-31 0
Prefunding balanced used to offset prior years funding requirement 2019-12-31 0
Amount remaining of carryover balance 2019-12-31 0
Amount remaining of prefunding balance 2019-12-31 0
Present value of excess contributions 2019-12-31 183
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance 2019-12-31 194
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance 2019-12-31 0
Reductions in caryover balances due to elections or deemed elections 2019-12-31 0
Reductions in prefunding balances due to elections or deemed elections 2019-12-31 0
Balance of carryovers at beginning of current year 2019-12-31 0
Balance of prefunding at beginning of current year 2019-12-31 0
Total employer contributions 2019-12-31 10,276,674
Total employee contributions 2019-12-31 0
Contributions allocated toward unpaid minimum require contributions from prior years 2019-12-31 0
Contributions made to avoid restrictions adjusted to valuation date 2019-12-31 0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date 2019-12-31 9,672,407
Liquidity shortfalls end of Q1 2019-12-31 0
Liquidity shortfalls end of Q2 2019-12-31 0
Liquidity shortfalls end of Q3 2019-12-31 0
Liquidity shortfalls end of Q4 2019-12-31 0
Unpaid minimum required contributions for all prior years 2019-12-31 0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years 2019-12-31 0
Remaining amount of unpaid minimum required contributions 2019-12-31 0
Minimum required contributions for current year target normal cost 2019-12-31 1,500,000
Net shortfall amortization installment of oustanding balance 2019-12-31 47,008,784
Waiver amortization installment 2019-12-31 0
Total funding amount beforereflecting carryover/prefunding balances 2019-12-31 9,672,407
Carryover balance elected to use to offset funding requirement 2019-12-31 0
Prefunding balance elected to use to offset funding requirement 2019-12-31 0
Additional cash requirement 2019-12-31 9,672,407
Contributions allocatedtoward minimum required contributions for current year 2019-12-31 9,672,407
Unpaid minimum required contributions for current year 2019-12-31 0
Unpaid minimum required contributions for all years 2019-12-31 0
Total participants, beginning-of-year 2019-01-01 1,536
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 792
Number of retired or separated participants receiving benefits 2019-01-01 259
Number of other retired or separated participants entitled to future benefits 2019-01-01 532
Total of all active and inactive participants 2019-01-01 1,583
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 7
Total participants 2019-01-01 1,590
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
Number of participants with account balances 2019-01-01 27,969
2018: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 8,689
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 4,022
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 4,757
Total of all active and inactive participants 2018-01-01 8,779
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 10
Total participants 2018-01-01 8,789
Number of participants with account balances 2018-01-01 8,712
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 8,255
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 4,231
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 4,467
Total of all active and inactive participants 2017-01-01 8,698
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 10
Total participants 2017-01-01 8,708
Number of participants with account balances 2017-01-01 8,566
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 7,492
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 3,975
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 4,082
Total of all active and inactive participants 2016-01-01 8,057
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 8
Total participants 2016-01-01 8,065
Number of participants with account balances 2016-01-01 8,161
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 7,963
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 5,098
Number of other retired or separated participants entitled to future benefits 2015-01-01 3,044
Total of all active and inactive participants 2015-01-01 8,142
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 7
Total participants 2015-01-01 8,149
Number of participants with account balances 2015-01-01 7,941
2014: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 7,630
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 4,706
Number of other retired or separated participants entitled to future benefits 2014-01-01 3,235
Total of all active and inactive participants 2014-01-01 7,941
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 22
Total participants 2014-01-01 7,963
Number of participants with account balances 2014-01-01 7,784
2013: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 5,866
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 5,078
Number of retired or separated participants receiving benefits 2013-01-01 1
Number of other retired or separated participants entitled to future benefits 2013-01-01 2,546
Total of all active and inactive participants 2013-01-01 7,625
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 5
Total participants 2013-01-01 7,630
Number of participants with account balances 2013-01-01 7,509
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 124
2012: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 6,170
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 3,694
Number of retired or separated participants receiving benefits 2012-01-01 1
Number of other retired or separated participants entitled to future benefits 2012-01-01 2,168
Total of all active and inactive participants 2012-01-01 5,863
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 3
Total participants 2012-01-01 5,866
Number of participants with account balances 2012-01-01 5,662
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 124
2011: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 6,601
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 4,405
Number of retired or separated participants receiving benefits 2011-01-01 1
Number of other retired or separated participants entitled to future benefits 2011-01-01 1,760
Total of all active and inactive participants 2011-01-01 6,166
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 4
Total participants 2011-01-01 6,170
Number of participants with account balances 2011-01-01 6,049
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 119
2009: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 7,191
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 6,134
Number of retired or separated participants receiving benefits 2009-01-01 13
Number of other retired or separated participants entitled to future benefits 2009-01-01 1,068
Total of all active and inactive participants 2009-01-01 7,215
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 1
Total participants 2009-01-01 7,216
Number of participants with account balances 2009-01-01 7,065
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 170

Measure	Date	Value
2022: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	32,659
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	21,791
Number of retired or separated participants receiving benefits	2022-01-01	76
Number of other retired or separated participants entitled to future benefits	2022-01-01	13,625
Total of all active and inactive participants	2022-01-01	35,492
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	38
Total participants	2022-01-01	35,530
Number of participants with account balances	2022-01-01	34,335
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	3,021
2021: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	29,720
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	20,597
Number of retired or separated participants receiving benefits	2021-01-01	67
Number of other retired or separated participants entitled to future benefits	2021-01-01	12,707
Total of all active and inactive participants	2021-01-01	33,371
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	28
Total participants	2021-01-01	33,399
Number of participants with account balances	2021-01-01	32,369
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	2,860
2020: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	28,564
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	19,614
Number of retired or separated participants receiving benefits	2020-01-01	25
Number of other retired or separated participants entitled to future benefits	2020-01-01	10,971
Total of all active and inactive participants	2020-01-01	30,610
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	17
Total participants	2020-01-01	30,627
Number of participants with account balances	2020-01-01	29,473
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	303
2019: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2019 401k membership
Market value of plan assets	2019-12-31	240,170,494
Acturial value of plan assets	2019-12-31	258,027,347
Funding target for retired participants and beneficiaries receiving payment	2019-12-31	99,661,883
Number of terminated vested participants	2019-12-31	517
Fundng target for terminated vested participants	2019-12-31	70,533,320
Active participant vested funding target	2019-12-31	122,677,245
Number of active participants	2019-12-31	792
Total funding liabilities for active participants	2019-12-31	134,840,928
Total participant count	2019-12-31	1,536
Total funding target for all participants	2019-12-31	305,036,131
Balance at beginning of prior year after applicable adjustments	2019-12-31	0
Prefunding balance at beginning of prior year after applicable adjustments	2019-12-31	0
Carryover balanced portion elected for use to offset prior years funding requirement	2019-12-31	0
Prefunding balanced used to offset prior years funding requirement	2019-12-31	0
Amount remaining of carryover balance	2019-12-31	0
Amount remaining of prefunding balance	2019-12-31	0
Present value of excess contributions	2019-12-31	183
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance	2019-12-31	194
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance	2019-12-31	0
Reductions in caryover balances due to elections or deemed elections	2019-12-31	0
Reductions in prefunding balances due to elections or deemed elections	2019-12-31	0
Balance of carryovers at beginning of current year	2019-12-31	0
Balance of prefunding at beginning of current year	2019-12-31	0
Total employer contributions	2019-12-31	10,276,674
Total employee contributions	2019-12-31	0
Contributions allocated toward unpaid minimum require contributions from prior years	2019-12-31	0
Contributions made to avoid restrictions adjusted to valuation date	2019-12-31	0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date	2019-12-31	9,672,407
Liquidity shortfalls end of Q1	2019-12-31	0
Liquidity shortfalls end of Q2	2019-12-31	0
Liquidity shortfalls end of Q3	2019-12-31	0
Liquidity shortfalls end of Q4	2019-12-31	0
Unpaid minimum required contributions for all prior years	2019-12-31	0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years	2019-12-31	0
Remaining amount of unpaid minimum required contributions	2019-12-31	0
Minimum required contributions for current year target normal cost	2019-12-31	1,500,000
Net shortfall amortization installment of oustanding balance	2019-12-31	47,008,784
Waiver amortization installment	2019-12-31	0
Total funding amount beforereflecting carryover/prefunding balances	2019-12-31	9,672,407
Carryover balance elected to use to offset funding requirement	2019-12-31	0
Prefunding balance elected to use to offset funding requirement	2019-12-31	0
Additional cash requirement	2019-12-31	9,672,407
Contributions allocatedtoward minimum required contributions for current year	2019-12-31	9,672,407
Unpaid minimum required contributions for current year	2019-12-31	0
Unpaid minimum required contributions for all years	2019-12-31	0
Total participants, beginning-of-year	2019-01-01	1,536
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	792
Number of retired or separated participants receiving benefits	2019-01-01	259
Number of other retired or separated participants entitled to future benefits	2019-01-01	532
Total of all active and inactive participants	2019-01-01	1,583
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	7
Total participants	2019-01-01	1,590
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
Number of participants with account balances	2019-01-01	27,969
2018: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	8,689
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	4,022
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	4,757
Total of all active and inactive participants	2018-01-01	8,779
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	10
Total participants	2018-01-01	8,789
Number of participants with account balances	2018-01-01	8,712
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	8,255
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	4,231
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	4,467
Total of all active and inactive participants	2017-01-01	8,698
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	10
Total participants	2017-01-01	8,708
Number of participants with account balances	2017-01-01	8,566
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	7,492
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	3,975
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	4,082
Total of all active and inactive participants	2016-01-01	8,057
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	8
Total participants	2016-01-01	8,065
Number of participants with account balances	2016-01-01	8,161
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	7,963
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	5,098
Number of other retired or separated participants entitled to future benefits	2015-01-01	3,044
Total of all active and inactive participants	2015-01-01	8,142
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	7
Total participants	2015-01-01	8,149
Number of participants with account balances	2015-01-01	7,941
2014: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	7,630
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	4,706
Number of other retired or separated participants entitled to future benefits	2014-01-01	3,235
Total of all active and inactive participants	2014-01-01	7,941
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	22
Total participants	2014-01-01	7,963
Number of participants with account balances	2014-01-01	7,784
2013: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	5,866
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	5,078
Number of retired or separated participants receiving benefits	2013-01-01	1
Number of other retired or separated participants entitled to future benefits	2013-01-01	2,546
Total of all active and inactive participants	2013-01-01	7,625
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	5
Total participants	2013-01-01	7,630
Number of participants with account balances	2013-01-01	7,509
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	124
2012: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	6,170
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	3,694
Number of retired or separated participants receiving benefits	2012-01-01	1
Number of other retired or separated participants entitled to future benefits	2012-01-01	2,168
Total of all active and inactive participants	2012-01-01	5,863
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	3
Total participants	2012-01-01	5,866
Number of participants with account balances	2012-01-01	5,662
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	124
2011: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	6,601
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	4,405
Number of retired or separated participants receiving benefits	2011-01-01	1
Number of other retired or separated participants entitled to future benefits	2011-01-01	1,760
Total of all active and inactive participants	2011-01-01	6,166
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	4
Total participants	2011-01-01	6,170
Number of participants with account balances	2011-01-01	6,049
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	119
2009: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	7,191
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	6,134
Number of retired or separated participants receiving benefits	2009-01-01	13
Number of other retired or separated participants entitled to future benefits	2009-01-01	1,068
Total of all active and inactive participants	2009-01-01	7,215
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	1
Total participants	2009-01-01	7,216
Number of participants with account balances	2009-01-01	7,065
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	170

Financial Data on TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN

Measure	Date	Value
2022 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2022 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2022-12-31	$-44,615,113
Total unrealized appreciation/depreciation of assets	2022-12-31	$-44,615,113
Total income from all sources (including contributions)	2022-12-31	$-437,931,217
Total loss/gain on sale of assets	2022-12-31	$-28,318,438
Total of all expenses incurred	2022-12-31	$460,957,021
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$457,078,101
Expenses. Certain deemed distributions of participant loans	2022-12-31	$91,273
Value of total corrective distributions	2022-12-31	$104,424
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$457,210,837
Value of total assets at end of year	2022-12-31	$4,540,674,656
Value of total assets at beginning of year	2022-12-31	$5,439,562,894
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$3,683,223
Total interest from all sources	2022-12-31	$1,961,829
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$10,069,917
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$3,232,936
Assets. Corporate prefeered stocks other than exployer securities at end of year	2022-12-31	$170,858
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2022-12-31	$78,012
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$190,603,805
Participant contributions at end of year	2022-12-31	$33,626,482
Participant contributions at beginning of year	2022-12-31	$32,539,661
Participant contributions at end of year	2022-12-31	$1,119,242
Participant contributions at beginning of year	2022-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$37,719,721
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-12-31	$9,206
Administrative expenses (other) incurred	2022-12-31	$1,436,797
Total non interest bearing cash at end of year	2022-12-31	$141,072
Total non interest bearing cash at beginning of year	2022-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-898,888,238
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$4,540,674,656
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$5,439,562,894
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Investment advisory and management fees	2022-12-31	$2,246,426
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$3,939,138,171
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$4,832,855,218
Interest on participant loans	2022-12-31	$1,284,359
Income. Interest from US Government securities	2022-12-31	$3,601
Income. Interest from corporate debt instruments	2022-12-31	$4,810
Value of interest in common/collective trusts at end of year	2022-12-31	$195,845,138
Value of interest in common/collective trusts at beginning of year	2022-12-31	$185,096,637
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2022-12-31	$47,731,357
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2022-12-31	$42,901,115
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2022-12-31	$42,901,115
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2022-12-31	$669,059
Asset value of US Government securities at end of year	2022-12-31	$3,248,802
Asset value of US Government securities at beginning of year	2022-12-31	$96,145
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-837,566,366
Net investment gain or loss from common/collective trusts	2022-12-31	$3,326,117
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Assets. Invements in employer securities at end of year	2022-12-31	$13,313,209
Assets. Invements in employer securities at beginning of year	2022-12-31	$12,544,378
Contributions received in cash from employer	2022-12-31	$228,887,311
Employer contributions (assets) at end of year	2022-12-31	$158,126,861
Employer contributions (assets) at beginning of year	2022-12-31	$146,935,237
Income. Dividends from preferred stock	2022-12-31	$7,283
Income. Dividends from common stock	2022-12-31	$6,829,698
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$457,078,101
Asset. Corporate debt instrument debt (other) at end of year	2022-12-31	$391,984
Asset. Corporate debt instrument debt (other) at beginning of year	2022-12-31	$382,258
Assets. Corporate common stocks other than exployer securities at end of year	2022-12-31	$147,821,480
Assets. Corporate common stocks other than exployer securities at beginning of year	2022-12-31	$186,125,027
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Aggregate proceeds on sale of assets	2022-12-31	$206,291,384
Aggregate carrying amount (costs) on sale of assets	2022-12-31	$234,609,822
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	FORVIS, LLP
Accountancy firm EIN	2022-12-31	440160260
2021 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2021 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2021-12-31	$66,589,262
Total unrealized appreciation/depreciation of assets	2021-12-31	$66,589,262
Total income from all sources (including contributions)	2021-12-31	$1,155,760,661
Total loss/gain on sale of assets	2021-12-31	$23,102,384
Total of all expenses incurred	2021-12-31	$479,959,130
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$476,073,729
Expenses. Certain deemed distributions of participant loans	2021-12-31	$203,215
Value of total corrective distributions	2021-12-31	$84,371
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$435,466,903
Value of total assets at end of year	2021-12-31	$5,439,562,894
Value of total assets at beginning of year	2021-12-31	$4,763,761,363
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$3,597,815
Total interest from all sources	2021-12-31	$1,377,976
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$11,958,570
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$4,690,839
Assets. Corporate prefeered stocks other than exployer securities at end of year	2021-12-31	$78,012
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2021-12-31	$300,796
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$174,574,561
Participant contributions at end of year	2021-12-31	$32,539,661
Participant contributions at beginning of year	2021-12-31	$30,959,327
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$49,964,014
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-12-31	$9,206
Administrative expenses (other) incurred	2021-12-31	$1,239,923
Total non interest bearing cash at end of year	2021-12-31	$0
Total non interest bearing cash at beginning of year	2021-12-31	$148,907
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$675,801,531
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$5,439,562,894
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$4,763,761,363
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$2,357,892
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$4,832,855,218
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$4,163,294,843
Interest on participant loans	2021-12-31	$1,353,652
Income. Interest from US Government securities	2021-12-31	$2,410
Income. Interest from corporate debt instruments	2021-12-31	$3,053
Value of interest in common/collective trusts at end of year	2021-12-31	$185,096,637
Value of interest in common/collective trusts at beginning of year	2021-12-31	$197,377,085
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$42,901,115
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$48,268,432
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$48,268,432
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2021-12-31	$18,861
Asset value of US Government securities at end of year	2021-12-31	$96,145
Asset value of US Government securities at beginning of year	2021-12-31	$101,777
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$614,715,022
Net investment gain or loss from common/collective trusts	2021-12-31	$2,550,544
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Assets. Invements in employer securities at end of year	2021-12-31	$12,544,378
Assets. Invements in employer securities at beginning of year	2021-12-31	$18,528,729
Contributions received in cash from employer	2021-12-31	$210,928,328
Employer contributions (assets) at end of year	2021-12-31	$146,935,237
Employer contributions (assets) at beginning of year	2021-12-31	$139,665,494
Income. Dividends from preferred stock	2021-12-31	$5,275
Income. Dividends from common stock	2021-12-31	$7,262,456
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$476,073,729
Asset. Corporate debt instrument debt (other) at end of year	2021-12-31	$382,258
Asset. Corporate debt instrument debt (other) at beginning of year	2021-12-31	$124,516
Assets. Corporate common stocks other than exployer securities at end of year	2021-12-31	$186,125,027
Assets. Corporate common stocks other than exployer securities at beginning of year	2021-12-31	$164,991,457
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Aggregate proceeds on sale of assets	2021-12-31	$339,327,761
Aggregate carrying amount (costs) on sale of assets	2021-12-31	$316,225,377
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	FORVIS, LLP
Accountancy firm EIN	2021-12-31	440160260
2020 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2020 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$78,663,078
Total unrealized appreciation/depreciation of assets	2020-12-31	$78,663,078
Total transfer of assets to this plan	2020-12-31	$663,901
Total income from all sources (including contributions)	2020-12-31	$1,091,281,475
Total loss/gain on sale of assets	2020-12-31	$-4,464,848
Total of all expenses incurred	2020-12-31	$451,133,927
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$448,372,699
Expenses. Certain deemed distributions of participant loans	2020-12-31	$88,756
Value of total corrective distributions	2020-12-31	$15,073
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$431,861,842
Value of total assets at end of year	2020-12-31	$4,763,761,363
Value of total assets at beginning of year	2020-12-31	$4,122,949,914
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$2,657,399
Total interest from all sources	2020-12-31	$1,910,733
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$9,558,066
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$2,481,382
Assets. Corporate prefeered stocks other than exployer securities at end of year	2020-12-31	$300,796
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2020-12-31	$289,198
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$161,522,170
Participant contributions at end of year	2020-12-31	$30,959,327
Participant contributions at beginning of year	2020-12-31	$34,093,903
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$40,982,792
Administrative expenses (other) incurred	2020-12-31	$866,336
Total non interest bearing cash at end of year	2020-12-31	$148,907
Total non interest bearing cash at beginning of year	2020-12-31	$35,000
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$640,147,548
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$4,763,761,363
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$4,122,949,914
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Investment advisory and management fees	2020-12-31	$1,791,063
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$4,163,294,843
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$3,691,163,691
Interest on participant loans	2020-12-31	$1,703,370
Income. Interest from US Government securities	2020-12-31	$2,171
Income. Interest from corporate debt instruments	2020-12-31	$5,455
Value of interest in common/collective trusts at end of year	2020-12-31	$197,377,085
Value of interest in common/collective trusts at beginning of year	2020-12-31	$160,883,832
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$48,268,432
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$32,036,599
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$32,036,599
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$199,737
Asset value of US Government securities at end of year	2020-12-31	$101,777
Asset value of US Government securities at beginning of year	2020-12-31	$144,827
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$569,768,613
Net investment gain or loss from common/collective trusts	2020-12-31	$3,983,991
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Assets. Invements in employer securities at end of year	2020-12-31	$18,528,729
Assets. Invements in employer securities at beginning of year	2020-12-31	$21,763,957
Contributions received in cash from employer	2020-12-31	$229,356,880
Employer contributions (assets) at end of year	2020-12-31	$139,665,494
Employer contributions (assets) at beginning of year	2020-12-31	$56,964,091
Income. Dividends from preferred stock	2020-12-31	$15,169
Income. Dividends from common stock	2020-12-31	$7,061,515
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$448,372,699
Asset. Corporate debt instrument debt (other) at end of year	2020-12-31	$124,516
Asset. Corporate debt instrument debt (other) at beginning of year	2020-12-31	$190,865
Assets. Corporate common stocks other than exployer securities at end of year	2020-12-31	$164,991,457
Assets. Corporate common stocks other than exployer securities at beginning of year	2020-12-31	$125,383,951
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$349,175,730
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$353,640,578
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	BKD, LLP
Accountancy firm EIN	2020-12-31	440160260
2019 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2019 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2019-12-31	$10,209,984
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$1,850,004,627
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$61,995,074
Total income from all sources (including contributions)	2019-12-31	$61,995,074
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$9,673,492
Total of all expenses incurred	2019-12-31	$9,673,492
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$7,836,988
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$7,836,988
Expenses. Certain deemed distributions of participant loans	2019-12-31	$29,020
Value of total corrective distributions	2019-12-31	$32,332
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$10,276,674
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$10,276,674
Value of total assets at end of year	2019-12-31	$292,518,257
Value of total assets at end of year	2019-12-31	$292,518,257
Value of total assets at beginning of year	2019-12-31	$240,196,675
Value of total assets at beginning of year	2019-12-31	$240,196,675
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$1,836,504
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$1,836,504
Total interest from all sources	2019-12-31	$164,881
Total interest from all sources	2019-12-31	$164,881
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$3,709,971
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$3,709,971
Administrative expenses professional fees incurred	2019-12-31	$388,266
Administrative expenses professional fees incurred	2019-12-31	$388,266
Assets. Corporate prefeered stocks other than exployer securities at end of year	2019-12-31	$289,198
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2019-12-31	$54,581
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$15,000,000
Value of fidelity bond cover	2019-12-31	$15,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$64,370,145
Participant contributions at end of year	2019-12-31	$34,093,903
Participant contributions at beginning of year	2019-12-31	$10,869,367
Assets. Other investments not covered elsewhere at end of year	2019-12-31	$13,722,996
Assets. Other investments not covered elsewhere at end of year	2019-12-31	$13,722,996
Assets. Other investments not covered elsewhere at beginning of year	2019-12-31	$11,907,425
Assets. Other investments not covered elsewhere at beginning of year	2019-12-31	$11,907,425
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$14,629,621
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$204,730
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$204,730
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$14,083
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$14,083
Other income not declared elsewhere	2019-12-31	$515,571
Other income not declared elsewhere	2019-12-31	$515,571
Administrative expenses (other) incurred	2019-12-31	$951,041
Administrative expenses (other) incurred	2019-12-31	$951,041
Total non interest bearing cash at end of year	2019-12-31	$35,000
Total non interest bearing cash at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$52,321,582
Value of net income/loss	2019-12-31	$52,321,582
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$292,518,257
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$292,518,257
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$240,196,675
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$467,266
Investment advisory and management fees	2019-12-31	$467,266
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$80,144,433
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$80,144,433
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$65,405,899
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$65,405,899
Interest on participant loans	2019-12-31	$466,984
Interest earned on other investments	2019-12-31	$2,031
Income. Interest from US Government securities	2019-12-31	$2,174
Income. Interest from corporate debt instruments	2019-12-31	$8,448
Value of interest in common/collective trusts at end of year	2019-12-31	$184,575,469
Value of interest in common/collective trusts at beginning of year	2019-12-31	$149,653,118
Value of interest in common/collective trusts at beginning of year	2019-12-31	$149,653,118
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$8,088,957
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$11,983,385
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$11,983,385
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$11,983,385
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$11,983,385
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$162,850
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$162,850
Asset value of US Government securities at end of year	2019-12-31	$144,827
Asset value of US Government securities at beginning of year	2019-12-31	$226,740
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$11,728,662
Net investment gain or loss from common/collective trusts	2019-12-31	$35,599,315
Net investment gain or loss from common/collective trusts	2019-12-31	$35,599,315
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	Yes
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	Yes
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Assets. Invements in employer securities at end of year	2019-12-31	$21,763,957
Contributions received in cash from employer	2019-12-31	$10,276,674
Contributions received in cash from employer	2019-12-31	$10,276,674
Employer contributions (assets) at end of year	2019-12-31	$5,781,672
Employer contributions (assets) at end of year	2019-12-31	$5,781,672
Employer contributions (assets) at beginning of year	2019-12-31	$1,232,765
Employer contributions (assets) at beginning of year	2019-12-31	$1,232,765
Income. Dividends from preferred stock	2019-12-31	$3,922
Income. Dividends from common stock	2019-12-31	$2,853,763
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$7,836,988
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$7,836,988
Asset. Corporate debt instrument debt (other) at end of year	2019-12-31	$190,865
Asset. Corporate debt instrument debt (other) at beginning of year	2019-12-31	$367,216
Contract administrator fees	2019-12-31	$29,931
Contract administrator fees	2019-12-31	$29,931
Assets. Corporate common stocks other than exployer securities at end of year	2019-12-31	$125,383,951
Assets. Corporate common stocks other than exployer securities at beginning of year	2019-12-31	$97,357,958
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Aggregate proceeds on sale of assets	2019-12-31	$51,003,326
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$48,725,283
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	No
Opinion of an independent qualified public accountant for this plan	2019-12-31	Unqualified
Opinion of an independent qualified public accountant for this plan	2019-12-31	Unqualified
Accountancy firm name	2019-12-31	CROWE LLP
Accountancy firm name	2019-12-31	CROWE LLP
Accountancy firm EIN	2019-12-31	350921680
2018 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2018 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2018-12-31	$-1,194,031
Total unrealized appreciation/depreciation of assets	2018-12-31	$-1,194,031
Total income from all sources (including contributions)	2018-12-31	$42,763,677
Total loss/gain on sale of assets	2018-12-31	$2,418,716
Total of all expenses incurred	2018-12-31	$155,200,629
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$154,383,472
Expenses. Certain deemed distributions of participant loans	2018-12-31	$102,399
Value of total corrective distributions	2018-12-31	$53,238
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$157,032,939
Value of total assets at end of year	2018-12-31	$1,906,893,778
Value of total assets at beginning of year	2018-12-31	$2,019,330,730
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$661,520
Total interest from all sources	2018-12-31	$722,093
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$5,154,068
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$2,596,955
Assets. Corporate prefeered stocks other than exployer securities at end of year	2018-12-31	$54,581
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2018-12-31	$54,204
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$63,238,282
Participant contributions at end of year	2018-12-31	$10,869,367
Participant contributions at beginning of year	2018-12-31	$11,185,894
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$14,748,537
Other income not declared elsewhere	2018-12-31	$0
Administrative expenses (other) incurred	2018-12-31	$456,935
Total non interest bearing cash at end of year	2018-12-31	$0
Total non interest bearing cash at beginning of year	2018-12-31	$13,814
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-112,436,952
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$1,906,893,778
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$2,019,330,730
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$204,585
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$1,607,199,143
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$1,740,767,659
Interest on participant loans	2018-12-31	$426,849
Income. Interest from US Government securities	2018-12-31	$2,175
Income. Interest from corporate debt instruments	2018-12-31	$14,404
Value of interest in common/collective trusts at end of year	2018-12-31	$111,412,180
Value of interest in common/collective trusts at beginning of year	2018-12-31	$98,347,130
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$20,306,032
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$16,705,917
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$16,705,917
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$278,665
Asset value of US Government securities at end of year	2018-12-31	$226,740
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-123,661,146
Net investment gain/loss from pooled separate accounts	2018-12-31	$0
Net investment gain or loss from common/collective trusts	2018-12-31	$2,291,038
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$79,046,120
Employer contributions (assets) at end of year	2018-12-31	$59,100,561
Employer contributions (assets) at beginning of year	2018-12-31	$55,159,655
Income. Dividends from preferred stock	2018-12-31	$3,970
Income. Dividends from common stock	2018-12-31	$2,553,143
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$154,383,472
Asset. Corporate debt instrument debt (other) at end of year	2018-12-31	$367,216
Asset. Corporate debt instrument debt (other) at beginning of year	2018-12-31	$275,060
Assets. Corporate common stocks other than exployer securities at end of year	2018-12-31	$97,357,958
Assets. Corporate common stocks other than exployer securities at beginning of year	2018-12-31	$96,821,397
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Aggregate proceeds on sale of assets	2018-12-31	$55,558,926
Aggregate carrying amount (costs) on sale of assets	2018-12-31	$53,140,210
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	BKD, LLP
Accountancy firm EIN	2018-12-31	440160260
2017 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2017 401k financial data
Unrealized appreciation/depreciation of real estate assets	2017-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2017-12-31	$25,944,144
Total unrealized appreciation/depreciation of assets	2017-12-31	$25,944,144
Total transfer of assets to this plan	2017-12-31	$34,800,729
Total income from all sources (including contributions)	2017-12-31	$451,854,977
Total loss/gain on sale of assets	2017-12-31	$3,053,309
Total of all expenses incurred	2017-12-31	$185,052,874
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$184,370,508
Expenses. Certain deemed distributions of participant loans	2017-12-31	$27,784
Value of total corrective distributions	2017-12-31	$6,895
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$149,903,026
Value of total assets at end of year	2017-12-31	$2,019,330,730
Value of total assets at beginning of year	2017-12-31	$1,717,727,898
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$647,687
Total interest from all sources	2017-12-31	$571,193
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$4,166,781
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$2,032,257
Assets. Corporate prefeered stocks other than exployer securities at end of year	2017-12-31	$54,204
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2017-12-31	$42,364
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$62,191,260
Participant contributions at end of year	2017-12-31	$11,185,894
Participant contributions at beginning of year	2017-12-31	$12,673,884
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$12,816,975
Administrative expenses (other) incurred	2017-12-31	$447,243
Total non interest bearing cash at end of year	2017-12-31	$13,814
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$266,802,103
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$2,019,330,730
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$1,717,727,898
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Investment advisory and management fees	2017-12-31	$200,444
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$1,740,767,659
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$1,448,176,244
Interest on participant loans	2017-12-31	$426,435
Income. Interest from US Government securities	2017-12-31	$812
Income. Interest from corporate debt instruments	2017-12-31	$41,048
Value of interest in common/collective trusts at end of year	2017-12-31	$98,347,130
Value of interest in common/collective trusts at beginning of year	2017-12-31	$98,073,908
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$16,705,917
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$19,422,875
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$19,422,875
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$102,898
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$4,694,262
Net investment gain or loss from common/collective trusts	2017-12-31	$263,522,262
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$74,894,791
Employer contributions (assets) at end of year	2017-12-31	$55,159,655
Employer contributions (assets) at beginning of year	2017-12-31	$56,868,677
Income. Dividends from preferred stock	2017-12-31	$3,645
Income. Dividends from common stock	2017-12-31	$2,130,879
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$184,370,508
Asset. Corporate debt instrument debt (other) at end of year	2017-12-31	$275,060
Asset. Corporate debt instrument debt (other) at beginning of year	2017-12-31	$301,971
Assets. Corporate common stocks other than exployer securities at end of year	2017-12-31	$96,821,397
Assets. Corporate common stocks other than exployer securities at beginning of year	2017-12-31	$82,167,975
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Aggregate proceeds on sale of assets	2017-12-31	$40,689,801
Aggregate carrying amount (costs) on sale of assets	2017-12-31	$37,636,492
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	BKD, LLP
Accountancy firm EIN	2017-12-31	440160260
2016 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2016 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2016-12-31	$-306,201
Total unrealized appreciation/depreciation of assets	2016-12-31	$-306,201
Total transfer of assets to this plan	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$291,899,372
Total loss/gain on sale of assets	2016-12-31	$6,288,482
Total of all expenses incurred	2016-12-31	$113,797,174
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$113,197,834
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$148,677,781
Value of total assets at end of year	2016-12-31	$1,717,727,898
Value of total assets at beginning of year	2016-12-31	$1,539,625,700
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$599,340
Total interest from all sources	2016-12-31	$454,566
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$3,213,249
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$944,399
Administrative expenses professional fees incurred	2016-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2016-12-31	$42,364
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2016-12-31	$33,671
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$62,817,166
Participant contributions at end of year	2016-12-31	$12,673,884
Participant contributions at beginning of year	2016-12-31	$12,182,774
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$8,870,304
Other income not declared elsewhere	2016-12-31	$0
Administrative expenses (other) incurred	2016-12-31	$407,261
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$178,102,198
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$1,717,727,898
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$1,539,625,700
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Investment advisory and management fees	2016-12-31	$192,079
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$1,448,176,244
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$1,279,473,199
Interest on participant loans	2016-12-31	$423,575
Interest earned on other investments	2016-12-31	$0
Income. Interest from corporate debt instruments	2016-12-31	$30,991
Value of interest in common/collective trusts at end of year	2016-12-31	$98,073,908
Value of interest in common/collective trusts at beginning of year	2016-12-31	$93,512,969
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2016-12-31	$19,422,875
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2016-12-31	$15,496,172
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2016-12-31	$15,496,172
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2016-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$646,377
Net gain/loss from 103.12 investment entities	2016-12-31	$132,925,118
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$76,990,311
Employer contributions (assets) at end of year	2016-12-31	$56,868,677
Employer contributions (assets) at beginning of year	2016-12-31	$55,993,560
Income. Dividends from preferred stock	2016-12-31	$2,912
Income. Dividends from common stock	2016-12-31	$2,265,938
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$113,197,834
Asset. Corporate debt instrument debt (other) at end of year	2016-12-31	$301,971
Asset. Corporate debt instrument debt (other) at beginning of year	2016-12-31	$263,860
Assets. Corporate common stocks other than exployer securities at end of year	2016-12-31	$82,167,975
Assets. Corporate common stocks other than exployer securities at beginning of year	2016-12-31	$82,669,495
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Aggregate proceeds on sale of assets	2016-12-31	$41,770,181
Aggregate carrying amount (costs) on sale of assets	2016-12-31	$35,481,699
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	BKD, LLP
Accountancy firm EIN	2016-12-31	440160260
2015 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2015 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2015-12-31	$-5,486,406
Total unrealized appreciation/depreciation of assets	2015-12-31	$-5,486,406
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$127,143,785
Total loss/gain on sale of assets	2015-12-31	$1,040,422
Total of all expenses incurred	2015-12-31	$113,545,435
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$112,783,674
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$144,428,223
Value of total assets at end of year	2015-12-31	$1,539,625,700
Value of total assets at beginning of year	2015-12-31	$1,526,027,350
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$761,761
Total interest from all sources	2015-12-31	$453,936
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$3,559,174
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$1,283,727
Assets. Corporate prefeered stocks other than exployer securities at end of year	2015-12-31	$33,671
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2015-12-31	$41,463
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$59,705,244
Participant contributions at end of year	2015-12-31	$12,182,774
Participant contributions at beginning of year	2015-12-31	$11,759,010
Participant contributions at beginning of year	2015-12-31	$1,315,720
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$8,944,235
Administrative expenses (other) incurred	2015-12-31	$518,537
Total non interest bearing cash at beginning of year	2015-12-31	$10,000
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$13,598,350
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$1,539,625,700
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$1,526,027,350
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Investment advisory and management fees	2015-12-31	$243,224
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$1,279,473,199
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$1,253,389,516
Interest on participant loans	2015-12-31	$414,029
Income. Interest from corporate debt instruments	2015-12-31	$38,156
Value of interest in common/collective trusts at end of year	2015-12-31	$93,512,969
Value of interest in common/collective trusts at beginning of year	2015-12-31	$97,850,597
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2015-12-31	$15,496,172
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$15,576,654
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$15,576,654
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-12-31	$1,751
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-1,618,592
Net investment gain or loss from common/collective trusts	2015-12-31	$-15,232,972
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$75,778,744
Employer contributions (assets) at end of year	2015-12-31	$55,993,560
Employer contributions (assets) at beginning of year	2015-12-31	$52,949,095
Income. Dividends from preferred stock	2015-12-31	$2,495
Income. Dividends from common stock	2015-12-31	$2,272,952
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$112,783,674
Asset. Corporate debt instrument debt (other) at end of year	2015-12-31	$263,860
Asset. Corporate debt instrument debt (other) at beginning of year	2015-12-31	$298,891
Assets. Corporate common stocks other than exployer securities at end of year	2015-12-31	$82,669,495
Assets. Corporate common stocks other than exployer securities at beginning of year	2015-12-31	$92,836,404
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Aggregate proceeds on sale of assets	2015-12-31	$58,637,923
Aggregate carrying amount (costs) on sale of assets	2015-12-31	$57,597,501
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	BKD, LLP
Accountancy firm EIN	2015-12-31	440160260
2014 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2014 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2014-12-31	$12,616,650
Total unrealized appreciation/depreciation of assets	2014-12-31	$12,616,650
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$232,624,553
Total loss/gain on sale of assets	2014-12-31	$1,552,716
Total of all expenses incurred	2014-12-31	$111,904,866
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$111,116,161
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$132,101,767
Value of total assets at end of year	2014-12-31	$1,526,027,350
Value of total assets at beginning of year	2014-12-31	$1,405,307,663
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$788,705
Total interest from all sources	2014-12-31	$440,279
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$3,403,529
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$1,374,104
Assets. Corporate prefeered stocks other than exployer securities at end of year	2014-12-31	$41,463
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2014-12-31	$35,314
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$55,584,492
Participant contributions at end of year	2014-12-31	$11,759,010
Participant contributions at beginning of year	2014-12-31	$11,532,219
Participant contributions at end of year	2014-12-31	$1,315,720
Participant contributions at beginning of year	2014-12-31	$850,412
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$5,291,520
Other income not declared elsewhere	2014-12-31	$-1,349
Administrative expenses (other) incurred	2014-12-31	$515,415
Total non interest bearing cash at end of year	2014-12-31	$10,000
Total non interest bearing cash at beginning of year	2014-12-31	$1,800
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$120,719,687
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$1,526,027,350
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$1,405,307,663
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Investment advisory and management fees	2014-12-31	$273,290
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$1,253,389,516
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$1,150,490,400
Interest on participant loans	2014-12-31	$392,147
Income. Interest from corporate debt instruments	2014-12-31	$46,654
Value of interest in common/collective trusts at end of year	2014-12-31	$97,850,597
Value of interest in common/collective trusts at beginning of year	2014-12-31	$99,919,997
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$15,576,654
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2014-12-31	$15,245,837
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2014-12-31	$15,245,837
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$1,478
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$11,179
Net investment gain or loss from common/collective trusts	2014-12-31	$82,499,782
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$71,225,755
Employer contributions (assets) at end of year	2014-12-31	$52,949,095
Employer contributions (assets) at beginning of year	2014-12-31	$49,529,791
Income. Dividends from preferred stock	2014-12-31	$3,007
Income. Dividends from common stock	2014-12-31	$2,026,418
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$111,116,161
Asset. Corporate debt instrument debt (other) at end of year	2014-12-31	$298,891
Asset. Corporate debt instrument debt (other) at beginning of year	2014-12-31	$600,745
Assets. Corporate common stocks other than exployer securities at end of year	2014-12-31	$92,836,404
Assets. Corporate common stocks other than exployer securities at beginning of year	2014-12-31	$77,101,148
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Aggregate proceeds on sale of assets	2014-12-31	$63,877,705
Aggregate carrying amount (costs) on sale of assets	2014-12-31	$62,324,989
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	BKD, LLP
Accountancy firm EIN	2014-12-31	440160260
2013 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2013 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2013-12-31	$17,454,177
Total unrealized appreciation/depreciation of assets	2013-12-31	$17,454,177
Total transfer of assets to this plan	2013-12-31	$333,445,712
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$282,378,044
Total loss/gain on sale of assets	2013-12-31	$1,836,398
Total of all expenses incurred	2013-12-31	$82,385,467
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$82,007,163
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$106,740,236
Value of total assets at end of year	2013-12-31	$1,405,307,663
Value of total assets at beginning of year	2013-12-31	$871,869,374
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$378,304
Total interest from all sources	2013-12-31	$350,613
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$2,321,821
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$590,555
Assets. Corporate prefeered stocks other than exployer securities at end of year	2013-12-31	$35,314
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2013-12-31	$5,016
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$35,845,364
Participant contributions at end of year	2013-12-31	$11,532,219
Participant contributions at beginning of year	2013-12-31	$8,793,036
Participant contributions at end of year	2013-12-31	$850,412
Participant contributions at beginning of year	2013-12-31	$791,566
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$9,608,976
Administrative expenses (other) incurred	2013-12-31	$378,304
Total non interest bearing cash at end of year	2013-12-31	$1,800
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$199,992,577
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$1,405,307,663
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$871,869,374
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$1,150,490,400
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$688,071,592
Interest on participant loans	2013-12-31	$297,872
Income. Interest from corporate debt instruments	2013-12-31	$51,595
Value of interest in common/collective trusts at end of year	2013-12-31	$99,919,997
Value of interest in common/collective trusts at beginning of year	2013-12-31	$68,938,340
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2013-12-31	$15,245,837
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2013-12-31	$10,122,344
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2013-12-31	$10,122,344
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2013-12-31	$1,146
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$152,563,499
Net investment gain or loss from common/collective trusts	2013-12-31	$1,111,300
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$61,285,896
Employer contributions (assets) at end of year	2013-12-31	$49,529,791
Employer contributions (assets) at beginning of year	2013-12-31	$32,779,158
Income. Dividends from preferred stock	2013-12-31	$1,401
Income. Dividends from common stock	2013-12-31	$1,729,865
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$82,007,163
Asset. Corporate debt instrument debt (other) at end of year	2013-12-31	$600,745
Asset. Corporate debt instrument debt (other) at beginning of year	2013-12-31	$542,705
Assets. Corporate common stocks other than exployer securities at end of year	2013-12-31	$77,101,148
Assets. Corporate common stocks other than exployer securities at beginning of year	2013-12-31	$61,825,617
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Aggregate proceeds on sale of assets	2013-12-31	$38,752,710
Aggregate carrying amount (costs) on sale of assets	2013-12-31	$36,916,312
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	WOLF & COMPANY LLP
Accountancy firm EIN	2013-12-31	362985665
2012 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2012 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2012-12-31	$6,389,053
Total unrealized appreciation/depreciation of assets	2012-12-31	$6,389,053
Total income from all sources (including contributions)	2012-12-31	$184,897,508
Total loss/gain on sale of assets	2012-12-31	$2,208,008
Total of all expenses incurred	2012-12-31	$128,557,305
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$128,036,791
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$84,196,122
Value of total assets at end of year	2012-12-31	$871,869,374
Value of total assets at beginning of year	2012-12-31	$815,529,171
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$520,514
Total interest from all sources	2012-12-31	$372,872
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$2,142,401
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$368,305
Assets. Corporate prefeered stocks other than exployer securities at end of year	2012-12-31	$5,016
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2012-12-31	$17,361
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$35,627,129
Participant contributions at end of year	2012-12-31	$8,793,036
Participant contributions at beginning of year	2012-12-31	$10,186,266
Participant contributions at end of year	2012-12-31	$791,566
Participant contributions at beginning of year	2012-12-31	$934,339
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$4,342,156
Administrative expenses (other) incurred	2012-12-31	$520,514
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$56,340,203
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$871,869,374
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$815,529,171
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$688,071,592
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$622,424,420
Interest on participant loans	2012-12-31	$322,175
Income. Interest from corporate debt instruments	2012-12-31	$49,001
Value of interest in common/collective trusts at end of year	2012-12-31	$68,938,340
Value of interest in common/collective trusts at beginning of year	2012-12-31	$73,941,964
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2012-12-31	$10,122,344
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2012-12-31	$9,337,239
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2012-12-31	$9,337,239
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2012-12-31	$1,696
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$88,383,178
Net investment gain or loss from common/collective trusts	2012-12-31	$1,205,874
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$44,226,837
Employer contributions (assets) at end of year	2012-12-31	$32,779,158
Employer contributions (assets) at beginning of year	2012-12-31	$39,239,487
Income. Dividends from preferred stock	2012-12-31	$716
Income. Dividends from common stock	2012-12-31	$1,773,380
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$128,036,791
Asset. Corporate debt instrument debt (other) at end of year	2012-12-31	$542,705
Asset. Corporate debt instrument debt (other) at beginning of year	2012-12-31	$1,167,217
Assets. Corporate common stocks other than exployer securities at end of year	2012-12-31	$61,825,617
Assets. Corporate common stocks other than exployer securities at beginning of year	2012-12-31	$58,280,878
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Aggregate proceeds on sale of assets	2012-12-31	$40,449,507
Aggregate carrying amount (costs) on sale of assets	2012-12-31	$38,241,499
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	WOLF & COMPANY LLP
Accountancy firm EIN	2012-12-31	362985665
2011 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2011 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2011-12-31	$3,735,180
Total unrealized appreciation/depreciation of assets	2011-12-31	$3,735,180
Total income from all sources (including contributions)	2011-12-31	$91,050,460
Total loss/gain on sale of assets	2011-12-31	$926,233
Total of all expenses incurred	2011-12-31	$80,432,402
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$79,878,702
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$93,612,373
Value of total assets at end of year	2011-12-31	$815,529,171
Value of total assets at beginning of year	2011-12-31	$804,911,113
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$553,700
Total interest from all sources	2011-12-31	$416,746
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$2,084,313
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2011-12-31	$291,255
Assets. Corporate prefeered stocks other than exployer securities at end of year	2011-12-31	$17,361
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2011-12-31	$26,678
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$39,318,260
Participant contributions at end of year	2011-12-31	$10,186,266
Participant contributions at beginning of year	2011-12-31	$9,771,911
Participant contributions at end of year	2011-12-31	$934,339
Participant contributions at beginning of year	2011-12-31	$993,878
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$2,236,137
Total non interest bearing cash at beginning of year	2011-12-31	$13,460
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$10,618,058
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$815,529,171
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$804,911,113
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$622,424,420
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$628,954,461
Interest on participant loans	2011-12-31	$364,180
Interest earned on other investments	2011-12-31	$146
Income. Interest from US Government securities	2011-12-31	$69
Income. Interest from corporate debt instruments	2011-12-31	$51,450
Value of interest in common/collective trusts at end of year	2011-12-31	$73,941,964
Value of interest in common/collective trusts at beginning of year	2011-12-31	$66,457,996
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2011-12-31	$9,337,239
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2011-12-31	$5,439,078
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2011-12-31	$5,439,078
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2011-12-31	$901
Asset value of US Government securities at beginning of year	2011-12-31	$10,688
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-10,496,411
Net investment gain or loss from common/collective trusts	2011-12-31	$772,026
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$52,057,976
Employer contributions (assets) at end of year	2011-12-31	$39,239,487
Employer contributions (assets) at beginning of year	2011-12-31	$38,430,110
Income. Dividends from preferred stock	2011-12-31	$1,340
Income. Dividends from common stock	2011-12-31	$1,791,718
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$79,878,702
Asset. Corporate debt instrument debt (other) at end of year	2011-12-31	$1,167,217
Asset. Corporate debt instrument debt (other) at beginning of year	2011-12-31	$467,629
Contract administrator fees	2011-12-31	$553,700
Assets. Corporate common stocks other than exployer securities at end of year	2011-12-31	$58,280,878
Assets. Corporate common stocks other than exployer securities at beginning of year	2011-12-31	$54,345,224
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Aggregate proceeds on sale of assets	2011-12-31	$40,213,593
Aggregate carrying amount (costs) on sale of assets	2011-12-31	$39,287,360
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	WOLF & COMPANY LLP
Accountancy firm EIN	2011-12-31	362985665
2010 : TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2010 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2010-12-31	$-5,065,050
Total unrealized appreciation/depreciation of assets	2010-12-31	$-5,065,050
Total income from all sources (including contributions)	2010-12-31	$179,327,887
Total loss/gain on sale of assets	2010-12-31	$277,898
Total of all expenses incurred	2010-12-31	$88,083,635
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$87,763,074
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$101,748,802
Value of total assets at end of year	2010-12-31	$804,911,113
Value of total assets at beginning of year	2010-12-31	$713,666,861
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$320,561
Total interest from all sources	2010-12-31	$506,198
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$3,824,362
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$2,432,192
Assets. Corporate prefeered stocks other than exployer securities at end of year	2010-12-31	$26,678
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2010-12-31	$36,770
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$47,800,576
Participant contributions at end of year	2010-12-31	$9,771,911
Participant contributions at beginning of year	2010-12-31	$11,006,400
Participant contributions at end of year	2010-12-31	$993,878
Participant contributions at beginning of year	2010-12-31	$1,275,357
Total non interest bearing cash at end of year	2010-12-31	$13,460
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$91,244,252
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$804,911,113
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$713,666,861
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$628,954,461
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$494,341,061
Interest on participant loans	2010-12-31	$465,744
Interest earned on other investments	2010-12-31	$293
Income. Interest from US Government securities	2010-12-31	$138
Income. Interest from corporate debt instruments	2010-12-31	$36,971
Value of interest in common/collective trusts at end of year	2010-12-31	$66,457,996
Value of interest in common/collective trusts at beginning of year	2010-12-31	$62,171,866
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2010-12-31	$5,439,078
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2010-12-31	$2,384,947
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2010-12-31	$2,384,947
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2010-12-31	$3,052
Asset value of US Government securities at end of year	2010-12-31	$10,688
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$76,745,420
Net investment gain or loss from common/collective trusts	2010-12-31	$1,290,257
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$53,948,226
Employer contributions (assets) at end of year	2010-12-31	$38,430,110
Employer contributions (assets) at beginning of year	2010-12-31	$50,824,921
Income. Dividends from preferred stock	2010-12-31	$1,955
Income. Dividends from common stock	2010-12-31	$1,390,215
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$87,763,074
Asset. Corporate debt instrument debt (other) at end of year	2010-12-31	$467,629
Asset. Corporate debt instrument debt (other) at beginning of year	2010-12-31	$341,097
Contract administrator fees	2010-12-31	$320,561
Assets. Corporate common stocks other than exployer securities at end of year	2010-12-31	$54,345,224
Assets. Corporate common stocks other than exployer securities at beginning of year	2010-12-31	$91,284,442
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Aggregate proceeds on sale of assets	2010-12-31	$124,357,712
Aggregate carrying amount (costs) on sale of assets	2010-12-31	$124,079,814
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	WOLF & COMPANY LLP
Accountancy firm EIN	2010-12-31	362985665

Form 5500 Responses for TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN

2022: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2009: TAKEDA PHARMACEUTICAL U.S.A., INC. SAVINGS AND RETIREMENT PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	TAKEDA PHARMACEUTICAL U.S.A., INC.
Employer identification number (EIN):	134013710
NAIC Classification:	339900